Ignite Creation Date:
2025-12-24 @ 11:18 PM
Ignite Modification Date:
2026-02-02 @ 6:38 PM
Study NCT ID:
NCT06688656
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-11-14
First Post:
2024-11-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Chemotherapy Sequentially Combined with Sintilimab in Resectable EGFR-Mutant NSCLC
Sponsor:
Organization: